Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Mythic Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Mythic Therapeutics

Mythic Therapeutics

Mythic Therapeutics leverages FateControl tech for innovative ADCs, targeting cancer, sparing normal cells.

HQ
Waltham, MA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize cancer treatment, Mythic Therapeutics focuses on developing advanced Antibody Drug Conjugates (ADCs) using their proprietary FateControlâ„¢ technology. This innovative platform enhances the precision of ADCs, ensuring that chemotherapy is delivered directly to cancerous cells while sparing healthy tissues. By increasing the efficacy and reducing the toxicity of cancer treatments, Mythic Therapeutics aims to provide more effective and safer therapeutic options for a wide range of cancer types.

Notable figures associated with Mythic Therapeutics include experts in oncology and biotechnology, supported by a robust network of investors committed to advancing cancer treatment. The company has achieved significant milestones, including the successful development and application of FateControlâ„¢ technology, which has shown promising results in preclinical studies. Mythic Therapeutics' impact lies in its potential to transform the landscape of cancer therapy, offering hope for more targeted and less harmful treatment options.

Mythic Therapeutics - Similar Companies

Adcentrx Therapeutics logo

Adcentrx Therapeutics

adcentrx.com

PanTher Therapeutics logo

PanTher Therapeutics

panthertx.com

Mersana Therapeutics logo

Mersana Therapeutics

mersana.com

Fortis Therapeutics logo

Fortis Therapeutics

Mediar Therapeutics logo

Mediar Therapeutics

mediartx.com

MBrace Therapeutics logo

MBrace Therapeutics

mbracetrx.com

Window Therapeutics logo

Window Therapeutics

windowtx.com

Advanced Chemotherapy Technologies logo

Advanced Chemotherapy Technologies

Theradaptive logo

Theradaptive

theradaptive.com

Faeth Therapeutics logo

Faeth Therapeutics

Anthos Therapeutics logo

Anthos Therapeutics

Metheor Therapeutics logo

Metheor Therapeutics

Tactiva Therapeutics logo

Tactiva Therapeutics

Starton Therapeutics logo

Starton Therapeutics

Telo Therapeutics logo

Telo Therapeutics

Mythic Therapeutics - Quick Facts

Who are Mythic Therapeutics' competitors?

Companies similar to Mythic Therapeutics include Adcentrx Therapeutics, PanTher Therapeutics, Mersana Therapeutics and Fortis Therapeutics.

When was Mythic Therapeutics founded?

Mythic Therapeutics was founded in 2017.

Where is Mythic Therapeutics' headquarters located?

Mythic Therapeutics' headquarters is located in Waltham, MA, US.

When was Mythic Therapeutics' last funding round?

Mythic Therapeutics' most recent funding round was for $103M (USD) in December 2021.

How much has Mythic Therapeutics raised to-date?

As of Dec 15, 2021, Mythic Therapeutics has raised a total of $126.6M (USD).

How many employees does Mythic Therapeutics have?

Mythic Therapeutics has 46 employees as of Feb 5, 2024.

Mythic Therapeutics - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Antibody Drug Conjugates
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified